Document Detail

Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases.
MedLine Citation:
PMID:  23146970     Owner:  NLM     Status:  Publisher    
Background:Patients with bone metastases secondary to prostate cancer are predisposed to skeletal-related events (SREs), including spinal cord compression, pathological fracture, surgery to bone and radiotherapy to bone. The objective of this study was to document current patterns of healthcare utilization and costs of SREs in patients with prostate cancer and bone metastases.Methods:This was a retrospective, observational study using the Thomson MedStat MarketScan Commercial Claims and Encounters database from September 2002 to June 2011. Study subjects included all persons with claims for prostate cancer and for bone metastases, and one or more claims for an SRE. Unique SRE episodes were identified based on a gap of at least 90 days without an SRE claim, and classified by treatment setting (inpatient or outpatient) and SRE type (spinal cord compression, pathological fracture, surgery to bone or radiotherapy).Results:Of 3919 patients with prostate cancer and bone metastases, 2090 (53%) had one or more SRE episodes. Among 1237 patients who met all other criteria, there were 1623 SRE episodes over a mean (s.d.) follow-up of 16.1 (12.9) months. The percent of episodes that required inpatient treatment ranged from 14% (radiotherapy) to 82% (surgery to bone). On average, inpatient episodes with surgery to bone (n=36 episodes) were most costly (mean (s.e.) $88 838 ($11 830)/episode), whereas outpatient episodes with surgery to bone (n=8 episodes) were least costly (mean (s.e.) $4749 ($1690)/episode). Of the total SRE costs (mean (s.e.) $20 984 ($951)/episode), 41% were attributable to outpatient radiotherapy (n=1169 episodes), 23% to inpatient radiotherapy (n=184 episodes), and 19% to inpatient treatment of pathological fractures (n=101 episodes).Conclusions:In patients with prostate cancer and bone metastases, SREs are associated with high costs and hospitalizations.Prostate Cancer and Prostatic Disease advance online publication, 13 November 2012; doi:10.1038/pcan.2012.42.
M Hagiwara; T E Delea; M W Saville; K Chung
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-13
Journal Detail:
Title:  Prostate cancer and prostatic diseases     Volume:  -     ISSN:  1476-5608     ISO Abbreviation:  Prostate Cancer Prostatic Dis.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815755     Medline TA:  Prostate Cancer Prostatic Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Policy Analysis Inc. (PAI), Brookline, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Emergence of Complex Computational Structures From Chaotic Neural Networks Through Reward-Modulated ...
Next Document:  Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectom...